Walsh Helps Client Amgen Win U.S. Patent Battle on Arthritis Drug
Court sides with Amgen in Dispute over Biosimilars NEWARK, NJ, August 12, 2019 – Walsh client Amgen, Inc. prevailed in litigation filed in 2016 challenging two patents for Amgen’s arthritis…
read more